Does UnitedHealthcare Cover Repatha? Prior Auth, Costs, and Appeals

UnitedHealthcare does cover Repatha (evolocumab) on its commercial, Medicare, and Medicaid plans, but it almost always requires prior authorization and proof that you first tried a high-intensity statin. Repatha is the plan’s preferred PCSK9 inhibitor, so most members in this drug class are routed to it rather than to Praluent. Approval hinges on your diagnosis, your current LDL-C level, and documentation from your prescriber. If coverage is denied or your out-of-pocket cost is too high, both an appeals process and manufacturer programs can bring the price well below the roughly $640 to $780 monthly retail cost.1GoodRx. Repatha Price

What UnitedHealthcare Requires Before It Will Pay

A prescriber has to submit a prior authorization showing you meet the plan’s clinical criteria. The criteria pair a qualifying diagnosis with an LDL-C threshold that still has not been reached after an adequate trial of other therapy.2UnitedHealthcare Provider. PCSK9 Lipotropics Prior Authorization Form

Qualifying Diagnoses and LDL-C Thresholds

  • Atherosclerotic cardiovascular disease (ASCVD) at very high risk: LDL-C at or above 55 mg/dL after at least 90 days of high-intensity statin therapy, or documented intolerance.
  • ASCVD not at very high risk: LDL-C at or above 70 mg/dL after 90 days of a high-intensity statin plus ezetimibe, or documented intolerance.
  • ASCVD with baseline LDL-C of 190 mg/dL or higher: LDL-C still at or above 70 mg/dL after 90 days of high-intensity statin therapy, or documented intolerance.
  • Primary hyperlipidemia without ASCVD (baseline LDL-C 190 mg/dL or higher): LDL-C at or above 100 mg/dL after 90 days of high-intensity statin therapy, or documented intolerance.
  • Homozygous or heterozygous familial hypercholesterolemia (HoFH or HeFH): LDL-C at or above 70 mg/dL after 90 days of a high-intensity statin with ezetimibe, or documented intolerance.

High-intensity statin therapy means rosuvastatin 20 mg or 40 mg, or atorvastatin 40 mg or 80 mg, at the maximally tolerated dose for roughly three months.2UnitedHealthcare Provider. PCSK9 Lipotropics Prior Authorization Form

Age and Dosing

Patients must be 18 or older for most indications. Children 10 and older qualify if they have HoFH or HeFH. UnitedHealthcare authorizes three dosing schedules: 140 mg every two weeks, 420 mg once monthly, or 420 mg every two weeks (the last reserved for HoFH patients who did not respond adequately to the monthly dose after 12 weeks, or who are receiving lipid apheresis).2UnitedHealthcare Provider. PCSK9 Lipotropics Prior Authorization Form

Statin Step Therapy

You generally need to show about three months on a maximally tolerated high-intensity statin, or document a reason statins are not appropriate: side effects, a medical contraindication, or a history of serious adverse reactions such as rhabdomyolysis. In February 2026, UnitedHealthcare dropped its separate requirement that patients also fail ezetimibe before Repatha, which shortened the path to approval for many members.3Empirical Health. PCSK9 Inhibitor Insurance Coverage

Why Repatha and Not Praluent

UnitedHealthcare designates Repatha as its preferred PCSK9 antibody. Praluent (alirocumab) is generally excluded from coverage unless you have already tried Repatha and it failed, you cannot tolerate it, or you have a documented contraindication, and your prescriber must submit the Repatha trial date and the reason it did not work.4UnitedHealthcare Provider. Step Therapy – Praluent5UnitedHealthcare Provider. Prior Authorization Medical Necessity – Praluent

Leqvio (inclisiran) is covered but sits later in the sequence. To get Leqvio, you need either a history of failure or intolerance to a PCSK9 inhibitor like Repatha, or at least 12 weeks of high-intensity statin therapy. Leqvio cannot be used alongside Repatha.6UnitedHealthcare Provider. Leqvio Commercial Medical Benefit Drug Policy

What You’ll Pay Under a UnitedHealthcare Plan

The retail price of Repatha runs roughly $640 to $780 per month depending on the formulation.1GoodRx. Repatha Price What you actually pay depends on which UnitedHealthcare line you’re on and whether you tap manufacturer help.

Commercial Plans

If you have an employer-sponsored or marketplace plan, you’re likely eligible for Amgen’s Repatha copay card, which can reduce your out-of-pocket cost to as little as $25 for a one-month supply or $50 for a three-month supply. The card covers copays, coinsurance, and deductible charges up to the program’s annual maximum, with no income requirement. About 89% of commercial Repatha prescriptions end up costing $50 or less.7Repatha. Repatha Cost

Medicare Plans

Under Part D and Medicare Advantage drug plans, what you pay varies by benefit phase (deductible, initial coverage, coverage gap, catastrophic). Amgen reports that about 74% of Medicare Repatha prescriptions cost patients $50 or less per month, and members who qualify for the Part D Low Income Subsidy (Extra Help) may pay $12.65 or less.7Repatha. Repatha Cost The Amgen copay card is not available to Medicare beneficiaries; federal rules prohibit manufacturer copay assistance for government-funded coverage.

Medicaid Plans

Under UnitedHealthcare’s Medicaid managed-care plans, about 99% of Repatha prescriptions cost patients $10 or less per month.7Repatha. Repatha Cost

If UnitedHealthcare Denies Coverage

A denial can be challenged, and in many cases it should be.

Request a Coverage Determination or Exception

If Repatha is off-formulary or on a high cost-sharing tier, you or your prescriber can request an exception. For Medicare plans, start with a coverage determination request through OptumRx online, by phone using the number on your member ID card, or by faxing the Medicare prescription drug coverage determination request form to the plan.8UnitedHealthcare. Prescription Drug Appeals For commercial plans, the prescriber uses the OptumRx prior authorization portal or calls 1-800-711-4555.9UnitedHealthcare. Prescription Drug Lists

The prescriber must submit a supporting statement explaining why formulary alternatives would be less effective or cause adverse effects. Under Medicare rules, the plan has 72 hours to issue a standard decision, or 24 hours for expedited requests when your health is at serious risk.10Centers for Medicare and Medicaid Services. Medicare Part D Exceptions

File an Appeal

If the coverage determination is denied, you have 65 calendar days from the date on the denial notice to file a formal appeal, called a redetermination. Include your name, member ID, date of birth, the drug name, and supporting clinical documentation. Appeals can be submitted by mail, fax, or email to the Medicare Part D Appeals and Grievances Department.8UnitedHealthcare. Prescription Drug Appeals

Standard appeal decisions are due within seven calendar days; expedited appeals within 72 hours. A Level 1 denial moves automatically to Level 2 review by an Independent Review Entity that is separate from UnitedHealthcare.11UnitedHealthcare Community Plan. Appeals and Grievances Process

What Makes an Appeal Stronger

The decisive factor is clinical documentation from the prescriber. Amgen publishes a sample appeal letter identifying what insurers want to see: the specific reason cited for denial, your current LDL-C, a full treatment history showing what was tried and why it was insufficient, and why Repatha is medically necessary based on its FDA-approved indications.12Repatha HCP. Repatha Sample Appeals Letter You can also ask about a temporary supply of the medication while the appeal is pending.8UnitedHealthcare. Prescription Drug Appeals

Ways To Get Repatha Outside the Coverage Process

If you’ve been denied, you’re stuck in a high-deductible phase, or you simply want to skip prior authorization, three manufacturer programs are worth knowing about.

AmgenNow

Amgen launched AmgenNow in October 2025. It sells Repatha directly to patients for $239 per month, nearly 60% below the retail list price. The program is open to everyone regardless of insurance status, including Medicare and Medicaid beneficiaries, uninsured patients, and people with high-deductible plans. Patients who use AmgenNow are not subject to insurer step therapy or prior authorization, so it works as a practical workaround if UnitedHealthcare has denied the claim or the paperwork is dragging.13Amgen. Amgen Makes Repatha Available Through AmgenNow14American Journal of Managed Care. Amgen Direct-to-Patient Program Aims To Expand Access to Evolocumab

Repatha Copay Card

Commercially insured members can enroll in the copay card at Repatha.com or by calling 1-844-REPATHA (1-844-737-2842). It can cut monthly costs to as little as $25 and covers copays, coinsurance, and deductible charges up to the program’s annual maximum. There is no income test. It is not available to anyone with Medicare, Medicaid, or other government coverage.15Repatha. Repatha Enrollment

Amgen Safety Net Foundation

Uninsured patients who meet income limits can receive Repatha at no cost for up to 12 months through the Amgen Safety Net Foundation. The income ceiling is $47,880 per year for a single-person household and $64,920 for a household of two, with higher thresholds in Alaska and Hawaii. The standard track requires no insurance of any kind, but a separate pathway exists for certain Medicare Part D patients who have an affordability gap and have exhausted other financial assistance.16Amgen Safety Net Foundation. Eligibility17Amgen Safety Net Foundation. Application for Repatha